Business / Finance

RSS

RXi Pharmaceuticals acquires Apthera

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced the completion of its previously announced acquisition of Apthera, Inc.

15 Apr 2011

SXC enters definitive agreement to acquire MedMetrics

SXC Health Solutions Corp., announced today it has entered into a definitive agreement to acquire substantially all of the assets of MedMetrics Health Partners, Inc., the full-service PBM subsidiary of Public Sector Partners, Inc. which is affiliated with a major medical school.

12 Apr 2011

Shrink Nanotechnologies to acquire Nanopoint

Shrink Nanotechnologies, Inc., an innovative high technology company, announced today that it has executed a binding letter of intent to acquire 100% of Hawaii-based Nanopoint Inc., a biomedical instrumentation and microfluidics company with global distribution for its award-winning suites of life sciences products.

12 Apr 2011

Nano Terra announces acquisition of Surface Logix

Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development company founded by renowned Harvard scientist Professor George Whitesides. Surface Logix has made significant breakthroughs in enhancing the molecular functionality of pharmaceuticals and advancing several drug candidates.

12 Apr 2011

Biomet net sales increase 1% to $678 million for third fiscal quarter 2011

Biomet, Inc. announced today financial results for its third fiscal quarter ended February 28, 2011.

12 Apr 2011

VitaminSpice receives revised PO from West & Associates for $6.94 million

VitaminSpice has received a revised purchase order that increases the previous $5 million, March 9, 2011 Purchase Order, to $6.94 million. VitaminSpice received the revised PO from West and Associates, Las Vegas.

12 Apr 2011

Novelos Therapeutics acquires Cellectar

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that it has completed its acquisition of Cellectar, Inc., a Wisconsin-based drug development company, in a stock-for-stock transaction.

12 Apr 2011

Lantheus begins exchange offer for eligible holders

NLantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that on April 8, 2011 it commenced an exchange offer for eligible holders to exchange any and all of the company's outstanding unregistered 9.75% Senior Notes due 2017.

11 Apr 2011

Endo Pharmaceuticals to acquire American Medical Systems

Endo Pharmaceuticals and American Medical Systems today that they have entered into a definitive agreement under which Endo will acquire AMS, a leading provider of world-class devices and therapies for male and female pelvic health, for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of AMS debt.

11 Apr 2011

Sanofi-aventis acquires Genzyme

Sanofi-aventis announced today that it has completed its acquisition of Genzyme Corporation, which is now a wholly-owned subsidiary of sanofi-aventis.

11 Apr 2011

QAD and Strategic Information Group to host Southern California Life Sciences Executive Forum

QAD Inc., a leading provider of enterprise business software and services for global manufacturing companies and its partner, Strategic Information Group (Strategic), announced today they will host the Southern California Life Sciences Executive Forum on April 12, 2011.

8 Apr 2011

McKinley Infocapital to distribute Biofield Breast Diagnostic System in Korea

Biofield Corp. announced today that its 51% owned subsidiary, Sky Unicorn Holdings Ltd., has engaged McKinley Infocapital as its exclusive distributor in Korea for its flagship product, the Biofield Breast Diagnostic System (BDS). McKinley Infocapital, an international business consulting and investment management firm, has formed MacKay Life Sciences Korea to market and promote the BDS in Korea.

8 Apr 2011

Kaydon completes HAHN-Gasfedern acquisition

Kaydon Corporation today announced that it has completed the acquisition of all of the outstanding shares of HAHN-Gasfedern GmbH and related real estate and intangible property ("Hahn") from Ulrich Hahn e.K. pursuant to the definitive agreement announced on February 25, 2011.

8 Apr 2011

BSD Medical second quarter net loss decreases 19% to $1,554,000

BSD Medical Corporation, a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its second fiscal quarter ended February 28, 2011.

8 Apr 2011

Unity receives first order for new BD Italian Tablet press

Unity Management Group, Inc. is a Health Resource Company specializing in Physician, and Hospital Practice Management, Business Services, Billing Software and Technologies, along with Pharmacy Instrumentation, Calibration, Data Acquisition, and Equipment Distribution.

8 Apr 2011

Creekridge Capital reports record-breaking volume for first quarter 2011

Creekridge Capital LLC, a nationwide independent healthcare and technology vendor leasing company, announced record-breaking volume for first quarter 2011 that exceeds any previous first quarter volume throughout its history.

8 Apr 2011

The MED Group creates National Orthotics and Prosthetics Network

The MED Group, a Managed Health Care Associates, Inc. (MHA) company, and a leading group purchasing and business solutions company focused on Home Medical Equipment providers is pleased to announce the creation of The MED Group National Orthotics and Prosthetics Network. Tim Pederson (formerly of WestMed Rehab) has joined The MED Group and will be leading the development of The MED Group's National Orthotics & Prosthetics Network.

8 Apr 2011

Sangamo prices public offering of 6.7M shares of common stock

Sangamo BioSciences, Inc. today announced the pricing of its previously announced public offering of 6,700,000 shares of its common stock at a price to the public of $7.70 per share. The public offering is expected to close on or around Wednesday, April 13, 2011, subject to customary closing conditions.

8 Apr 2011

Novation adds St. Jude Medical to portfolio of Cardiac Rhythm Management products

Novation, the leading health care supply contracting company, announced today the addition of St. Jude Medical (St. Paul, MN) to its portfolio of agreements for Cardiac Rhythm Management products.

8 Apr 2011

HCP closes acquisition of HCR ManorCare facilities for $6.1 billion

HCP announced that it closed the acquisition of 334 post-acute, skilled nursing and assisted living facilities of HCR ManorCare for a total consideration of $6.1 billion in cash. In connection with the closing, HCP entered into a long-term triple-net master lease under which HCR ManorCare will continue to operate the facilities.

8 Apr 2011